Vivalis Articles

Merger between Intercell and Vivalis planned to complete soon

14 May 2013

Vivalis and Intercell announce "merger of equals"

18 December 2012

Vivalis in new EB66 cell line deal with Merial

18 July 2012

Vivalis signs another EB66 out-licensing deal for MAb production

14 March 2012

Vivalis opens new lab for antibody discovery; posts 112% revenue hike

25 January 2012

Sanofi Pasteur and Vivalis extend MAb accord

19 January 2012

Strong first-half 2011 for Vivalis, with net loss nearly halved

1 September 2011

Vivalis acquires single-cell antibody from SC World

28 April 2011

Kaketsuken initiates second trial of flu vaccine using Vivalis EB66 cell line

26 April 2011

Vivalis grants rights to EB66 cell line for human vaccine to unnamed company

15 April 2011

Sanofi-Aventis in licensing deal with Vivalis for MAb targeting infectious diseases and extends accord with Zealand for diabetes product

8 June 2010

Showing 1-11 of 11 articles

Go to beginningPrevious
  • 1
NextGo to end